치료용 단백질 시장 보고서(2026년)

Therapeutic proteins are pharmaceutical products that are genetically engineered forms of naturally occurring human proteins. These highly potent and fast-acting medicines are produced in laboratory environments for pharmaceutical applications. Therapeutic proteins have played a major role in transforming disease management because of their high in vivo effectiveness.

The main product types in the therapeutic proteins market include insulin, fusion proteins, erythropoietin, interferon, human growth hormone, and follicle-stimulating hormone. Insulin is a peptide hormone secreted by the beta cells of the pancreas and functions as the body's primary anabolic hormone. It regulates fat, carbohydrate, and protein metabolism by promoting glucose uptake from the bloodstream into fat, liver, and skeletal muscle cells. The different functions include enzymatic and regulatory activity, targeted activity, vaccines, and protein diagnostics, and these products are applied in areas such as metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others.

Tariffs have impacted the therapeutic proteins market by increasing costs associated with imported biologic raw materials, reagents, and bioprocessing equipment. This has placed cost pressure on insulin, fusion proteins, and erythropoietin segments, particularly in regions dependent on international supply chains such as Asia Pacific and Europe. Manufacturing timelines have also been affected due to higher import compliance requirements. At the same time, tariffs are encouraging localized biomanufacturing investments and strengthening domestic biologics production capabilities.

The therapeutic proteins market research report is one of a series of new reports from The Business Research Company that provides therapeutic proteins market statistics, including therapeutic proteins industry global market size, regional shares, competitors with a therapeutic proteins market share, detailed therapeutic proteins market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic proteins industry. This therapeutic proteins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic proteins market size has grown rapidly in recent years. It will grow from $177.3 billion in 2025 to $200.43 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to successful commercialization of insulin therapies, rising prevalence of chronic diseases, strong clinical efficacy of protein drugs, growth of biotechnology research, increased regulatory approvals.

The therapeutic proteins market size is expected to see rapid growth in the next few years. It will grow to $332.37 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to expanding oncology and immunology pipelines, increasing biologics approvals, rising investment in biopharmaceutical R&D, growing adoption of biosimilars, improved manufacturing scalability. Major trends in the forecast period include expansion of recombinant protein therapies, rising demand for targeted biologics, growth of personalized protein medicines, increased adoption of long acting proteins, advancement in protein expression systems.

The increasing prevalence of chronic diseases, including diabetes, is expected to fuel the growth of the therapeutic protein market in the years ahead. Chronic diseases are conditions that generally last for one year or more, limit daily activities, require continuous medical attention, or both. Diabetes is a long-term disorder in which the body either fails to produce adequate insulin or cannot efficiently utilize the insulin it produces. Protein-based therapies, such as insulin and GLP-1 receptor agonists, are widely used in diabetes management to help control blood glucose levels. These treatments promote insulin secretion in response to elevated blood sugar levels while simultaneously reducing glucagon secretion, a hormone that raises blood glucose levels. For instance, in May 2024, according to the British Diabetic Association (Diabetes UK), a UK-based charity supporting patients, healthcare professionals, and research, around 4.4 million people in the UK were living with a diagnosed form of diabetes during 2022-23. Among these individuals, approximately 8% had type 1 diabetes, nearly 90% had type 2 diabetes, and the remaining 2% were affected by other less common forms. As a result, the growing burden of chronic diseases such as diabetes is driving the expansion of the therapeutic protein market.

Major companies operating in the therapeutic protein market are also focusing on launching advanced media systems to meet rising demand and enhance their competitive position. Media systems for therapeutic proteins are specialized manufacturing platforms developed to optimize the production of therapeutic monoclonal antibodies and other protein-based drugs. For example, in July 2023, Lonza Group AG, a Switzerland-based pharmaceutical manufacturing company, introduced the TheraPRO CHO (Chinese Hamster Ovary) Media System, a novel cell culture platform designed to improve productivity and product quality in therapeutic protein manufacturing. This two-part, chemically defined production system offers ease of use, simplified media preparation, complete scalability, and is supported by technical experts who provide comprehensive troubleshooting assistance.

In March 2024, Merck & Co. Inc., a US-based pharmaceutical company, acquired Harpoon Therapeutics in a deal valued at $680 million. This acquisition strengthens Merck's oncology pipeline by adding a portfolio of innovative T-cell engagers, including HPN328 (MK-6070). This investigational therapy targets delta-like ligand 3 (DLL3) to enhance T-cell engagement against cancer. Harpoon Therapeutics is a US-based company specializing in therapeutic proteins.

Major companies operating in the therapeutic proteins market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Co., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk A/S, Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring LLC, Chugai Pharmaceutical Co. Ltd., Biogen Inc., Kyowa Kirin Co. Ltd., Oramed Pharmaceuticals Inc., Sandoz International GmbH, Hualan Biological Engineering Inc., Genentech Inc., ProBiogen AG, Diasome Pharmaceuticals Inc., Generex Biotechnology Corp., GeneScience Pharmaceuticals Co. Ltd.

North America was the largest region in the therapeutic proteins market in 2025. The regions covered in the therapeutic proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic proteins market consists of sales of antibody-based drugs, FC fusion proteins, and anticoagulants. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Therapeutic Proteins Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses therapeutic proteins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic proteins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The therapeutic proteins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Insulin; Fusion Protein; Erythropoietin; Interferon; Human Growth Hormone; Follicle Stimulating Hormone
• 2) By Function: Enzymatic And Regulatory Activity; Special Targeting Activity; Vaccines
• 3) By Application: Metabolic Disorders; Immunologic Disorders; Hematological Disorders; Cancer; Hormonal Disorders; Genetic Disorders; Other Applications
• Subsegments:
• 1) By Insulin: Rapid-Acting Insulin; Short-Acting Insulin; Intermediate-Acting Insulin; Long-Acting Insulin
• 2) By Fusion Protein: Tnf-Alpha Inhibitors; Anti-Cd20 Fusion Proteins; Other Targeted Fusion Proteins
• 3) By Erythropoietin: Epoetin Alpha; Darbepoetin Alfa; Other Erythropoietin Variants
• 4) By Interferon: Interferon Alpha; Interferon Beta; Interferon Gamma
• 5) By Human Growth Hormone: Somatropin; Somatrem
• 6) By Follicle Stimulating Hormone: Follitropin Alpha; Follitropin Beta
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis International AG; Sanofi S.A; Bristol Myers Squibb Co.; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Eli Lilly and Company; Boehringer Ingelheim International GmbH; Amgen Inc.; Novo Nordisk A/S; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; CSL Behring LLC; Chugai Pharmaceutical Co. Ltd.; Biogen Inc.; Kyowa Kirin Co. Ltd.; Oramed Pharmaceuticals Inc.; Sandoz International GmbH; Hualan Biological Engineering Inc.; Genentech Inc.; ProBiogen AG; Diasome Pharmaceuticals Inc.; Generex Biotechnology Corp.; GeneScience Pharmaceuticals Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Therapeutic Proteins Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Therapeutic Proteins Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Therapeutic Proteins Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Therapeutic Proteins Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Expansion Of Recombinant Protein Therapies
  • 4.2.2 Rising Demand For Targeted Biologics
  • 4.2.3 Growth Of Personalized Protein Medicines
  • 4.2.4 Increased Adoption Of Long Acting Proteins
  • 4.2.5 Advancement In Protein Expression Systems

5. Therapeutic Proteins Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Biopharmaceutical Companies
• 5.4 Research Institutes
• 5.5 Contract Manufacturing Organizations

6. Therapeutic Proteins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Therapeutic Proteins Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Therapeutic Proteins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Therapeutic Proteins Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Therapeutic Proteins Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Therapeutic Proteins Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Therapeutic Proteins Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Therapeutic Proteins Market Segmentation

• 9.1. Global Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone
• 9.2. Global Therapeutic Proteins Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzymatic And Regulatory Activity, Special Targeting Activity, Vaccines
• 9.3. Global Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications
• 9.4. Global Therapeutic Proteins Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin
• 9.5. Global Therapeutic Proteins Market, Sub-Segmentation Of Fusion Protein, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tnf-Alpha Inhibitors, Anti-Cd20 Fusion Proteins, Other Targeted Fusion Proteins
• 9.6. Global Therapeutic Proteins Market, Sub-Segmentation Of Erythropoietin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Epoetin Alpha, Darbepoetin Alfa, Other Erythropoietin Variants
• 9.7. Global Therapeutic Proteins Market, Sub-Segmentation Of Interferon, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Interferon Alpha, Interferon Beta, Interferon Gamma
• 9.8. Global Therapeutic Proteins Market, Sub-Segmentation Of Human Growth Hormone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Somatropin, Somatrem
• 9.9. Global Therapeutic Proteins Market, Sub-Segmentation Of Follicle Stimulating Hormone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Follitropin Alpha, Follitropin Beta

10. Therapeutic Proteins Market Regional And Country Analysis

• 10.1. Global Therapeutic Proteins Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Therapeutic Proteins Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Therapeutic Proteins Market

• 11.1. Asia-Pacific Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Therapeutic Proteins Market

• 12.1. China Therapeutic Proteins Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Therapeutic Proteins Market

• 13.1. India Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Therapeutic Proteins Market

• 14.1. Japan Therapeutic Proteins Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Therapeutic Proteins Market

• 15.1. Australia Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Therapeutic Proteins Market

• 16.1. Indonesia Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Therapeutic Proteins Market

• 17.1. South Korea Therapeutic Proteins Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Therapeutic Proteins Market

• 18.1. Taiwan Therapeutic Proteins Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Therapeutic Proteins Market

• 19.1. South East Asia Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Therapeutic Proteins Market

• 20.1. Western Europe Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Therapeutic Proteins Market

• 21.1. UK Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Therapeutic Proteins Market

• 22.1. Germany Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Therapeutic Proteins Market

• 23.1. France Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Therapeutic Proteins Market

• 24.1. Italy Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Therapeutic Proteins Market

• 25.1. Spain Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Therapeutic Proteins Market

• 26.1. Eastern Europe Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Therapeutic Proteins Market

• 27.1. Russia Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Therapeutic Proteins Market

• 28.1. North America Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Therapeutic Proteins Market

• 29.1. USA Therapeutic Proteins Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Therapeutic Proteins Market

• 30.1. Canada Therapeutic Proteins Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Therapeutic Proteins Market

• 31.1. South America Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Therapeutic Proteins Market

• 32.1. Brazil Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Therapeutic Proteins Market

• 33.1. Middle East Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Therapeutic Proteins Market

• 34.1. Africa Therapeutic Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Therapeutic Proteins Market, Segmentation By Product Type, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Therapeutic Proteins Market Regulatory and Investment Landscape

36. Therapeutic Proteins Market Competitive Landscape And Company Profiles

• 36.1. Therapeutic Proteins Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Therapeutic Proteins Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Therapeutic Proteins Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Therapeutic Proteins Market Other Major And Innovative Companies

• Novartis International AG, Sanofi S.A, Bristol Myers Squibb Co., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk A/S, Baxter International Inc., Teva Pharmaceutical Industries Ltd, CSL Behring LLC, Chugai Pharmaceutical Co. Ltd, Biogen Inc

38. Global Therapeutic Proteins Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Therapeutic Proteins Market

40. Therapeutic Proteins Market High Potential Countries, Segments and Strategies

• 40.1 Therapeutic Proteins Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Therapeutic Proteins Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Therapeutic Proteins Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer